Literature DB >> 12548095

Effects of long-term treatment with candesartan on organ damages in sinoaortic denervated rats.

He-Hui Xie1, Chao-Yu Miao, Jian-Guo Liu, Ding-Feng Su.   

Abstract

The study was designed to observe the effects of long-term treatment with candesartan cilexetil (candesartan) on blood pressure (BP), blood pressure variability (BPV), baroreflex sensitivity (BRS) and end-organ damage (EOD) in sinoaortic denervated (SAD) rats. Candesartan was mixed in rat chow at an estimated dose of 3 mg/kg/day. After 12 weeks of drug administration, rats were instrumented to determine BP, BPV and BRS in conscious state. Organ damage was estimated by observation of morphologic changes. When compared with sham-operated rats, SAD rats exhibited increased BPV, decreased BRS, and normal BP and plasma angiotensin II level. Left ventricular and aortic hypertrophies and renal lesion were found in SAD rats. Candesartan significantly decreased BP and BPV, ameliorated impaired BRS, increased plasma angiotensin II level and obviously diminished the EOD in SAD rats. Multiple-regression analysis shows that decrease in left ventricular hypertrophy was mainly related to decrease in systolic BPV. Decrease in aortic hypertrophy was mainly determined by increase in BRS and decrease in systolic BP. Amelioration in renal lesion was predicted by increase in BRS and decrease in systolic BPV. BRS was the most important determinant for renal lesion and aortic hypertrophy in SAD rats. In addition, plasma angiotensin II level was higher in candesartan-treated rats. In conclusion, long-term treatment with candesartan prevented SAD-induced organ damage. Restoration of arterial baroreflex function, decrease in BPV, and blockade of activated renin-angiotensin system may contribute to the organ protective action of candesartan in SAD rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548095     DOI: 10.1097/00005344-200302000-00023

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.

Authors:  Wen Shang; Ping Han; Cheng-bing Yang; Xiao-wen Gu; Wei Zhang; Li-ping Xu; Shou-ting Fu; Ding-feng Su; He-hui Xie
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

2.  Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.

Authors:  Esam O Kamel; Wail M Gad-Elrab; Mohammed A Ahmed; Zuhair M Mohammedsaleh; Emad H M Hassanein; Fares E M Ali
Journal:  Biol Trace Elem Res       Date:  2022-05-19       Impact factor: 3.738

3.  Development of an Experimental Model to Study the Relationship Between Day-to-Day Variability in Blood Pressure and Aortic Stiffness.

Authors:  Camille Bouissou-Schurtz; Georges Lindesay; Véronique Regnault; Sophie Renet; Michel E Safar; Vincent Molinie; Hubert Dabire; Yvonnick Bezie
Journal:  Front Physiol       Date:  2015-12-08       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.